Oxytocin and vasopressin: Social neuropeptides

CNS Spectrums

Volumn 14, Issue 11, 2009, Pages 602-606

  Stein, Dan J ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; VASOPRESSIN DERIVATIVE;

ADULT; ANIMAL; BRAIN; CASE REPORT; FEMALE; GENETICS; HUMAN; MENTAL DISEASE; METABOLISM; PATHOLOGY; REVIEW; SOCIAL BEHAVIOR;

ADULT; ANIMALS; BRAIN; FEMALE; HUMANS; MENTAL DISORDERS; OXYTOCIN; SOCIAL BEHAVIOR; VASOPRESSINS;

EID: 77949382542     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900023841     Document Type: Article

References (57)

1. Heinrichs M, Domes G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:337-350.
2. Lee HJ, Macbeth AH, Pagani JH, Young WS 3rd. Oxytocin: The great facilitator of life. Prog Neurobiol. 2009;88:127-151.
3. Ebstein RP, Israel S, Lerer E, et al. Arginine Vasopressin and Oxytocin Modulate Human Social Behavior. Ann N Y Acad Sci. 2009;1167:87-102.
4. Insel TR. A neurobiological basis of social attachment. Am J Psychiatry. 1997;154:726-735.
5. Bora E, Yucel M, Allen NB. Neurobiology of human affiliative behaviour: implications for psychiatric disorders. Curr Opin Psychiatry. 2009;22:320-325.
6. Donaldson ZR, Young LJ. Oxytocin, Vasopressin, and the Neurogenetics of Sociality. Science. 2008;322:900-904.
7. Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003;54:1389-1398.
8. Thompson RR, George K, Walton JC, Orr SP, Benson J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci USA. 2006;103:7889-7894.
9. Insel TR. Is social attachment an addictive disorder? Physiol Behav. 2003;79:351-357.
10. Hammock EAD, Young LJ. Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc B Biol Sci. 2006;361:2187-2198.
11. Marazziti D, Dell'Osso MC. The role of oxytocin in neuropsychiatric disorders. Curr Med Chem. 2008;15:698-704.
12. Leckman JF, Goodman WK, North WG, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology. 1994;19:723-749.
13. Meyer-Lindenberg A. Impact of prosocial neuropeptides on human brain function. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:463-470.
14. Israel S, Lerer E, Shalev I, et al. Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:435-449.
15. Carter CS. Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? Behav Brain Res. 2007;176:170-186.
16. Heinrichs M, von Dawans B, Domes G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol. 2009;30:548-557.
17. de Vries GJ. Sex differences in vasopressin and oxytocin innervation of the brain. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:17-27.
18. Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005;308:245-248.
19. Viviani D, Stoop R. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:207-218.
20. Ferris CF. Functional magnetic resonance imaging and the neurobiology of vasopressin and oxytocin. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:305-320.
21. Febo M, Ferris CF. Functional imaging reveals maternal brain circuitry responsive to suckling and oxytocin in the lactating rat. Hormones and Behavior. 2005;48:92.
22. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005;435:673-676.
23. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC. Oxytocin improves "mind-reading" in humans. Biol Psychiatry. 2007;61:731-733.
24. Kirsch P, Esslinger C, Chen Q, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25:11489-11493.
25. Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry. 2007;62:1187-1190.
26. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron. 2008;58:639-650.
27. Petrovic P, Kalisch R, Singer T, Dolan RJ. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008;28:6607-6615.
28. Domes G, Lischke A, Berger C, et al. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology. In press.
29. Meyer-Lindenberg A, Kolachana B, Gold B, et al. Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry. 2009;14:968-975.
30. Pitman RK, Orr SP, Lasko NB. Effects of Intranasal Vasopressin and Oxytocin on Physiological Responding During Personal Combat Imagery in Vietnam Veterans with Posttraumatic-Stress-Disorder. Psychiatry Res. 1993;48:107-117.
31. McGregor IS, Callaghan PD, Hunt GE. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol. 2008;154:358-368.
32. Dempster EL, Burcescu I, Wigg K, et al. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry. 2007;64:1189-1195.
33. Goldman M, Marlow-O'Connor M, Torres I, Carter CS. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res. 2008;98:247-255.
34. Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS. A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine ("ecstasy"). Neuroscience. 2007;146:509-514.
35. Enck P, Klosterhalfen S. The story of O-is oxytocin the mediator of the placebo response? Neurogastroenterol Motil. 2009;21:347-350.
36. Knafo A, Plomin R. Prosocial behavior from early to middle childhood: Genetic and environmental influences on stability and change. Dev Psychol. 2006;42:771-786.
37. Brunton PJ, Russell JA. Keeping oxytocin neurons under control during stress in pregnancy. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:365-377.
38. Israel S, Lerer E, Shalev I, et al. The oxytocin receptor contributes to prosocial fund allocations in the dictator game and the social value orientations task. PLoS One. 2009;4:e5535.
39. Walum H, Westberg L, Henningsson S, et al. Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proc Natl Acad Sci USA. 2008;105:14153-14156.
40. Winslow JT, Shapiro L, Carter CS, Insel TR. Oxytocin and complex social-behavior - species comparisons. Psychopharmacol Bull. 1993;29:409-414.
41. Insel TR, Shapiro LE. Oxytocin Receptor Distribution Reflects Social-Organization in Monogamous and Polygamous Voles. Proc Natl Acad Sci USA. 1992;89:5981-5985.
42. Hammock EAD, Young LJ. Variation in the vasopressin V1a receptor promoter and expression: implications for inter- and intraspecific variation in social behaviour. Eur J Neurosci. 2002;16:399-402.
43. Lim MM, Wang ZX, Olazabal DE, Rex X, Terwilliger EF, Young LJ. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature. 2004;429:754-757.
44. Hammock EAD, Young LJ. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science. 2005;308:1630-1634.
45. Donaldson ZR, Kondrashov FA, Putnam A, et al. Evolution of a behavior-linked microsatellite-containing element in the 5 'flanking region of the primate AVPR1A gene. BMC Evol Biol. 2008;8:180.
46. Carter CS, Pournajafi-Nazarloo H, Kramer KM, et al. Oxytocin: Behavioral associations and potential as a salivary biomarker. Ann NY Acad Sci. 2007;1098:312-322.
47. Stein DJ. Empathy: At the heart of the mind. CNS Spectr. 2005;10:280-283.
48. Stein DJ, Vythilingum B. Love and attachment: the psychobiology of social bonding. CNS Spectr. 2009;14:239-242.
49. Stein DJ. How we see others: the psychobiology of schemas and transference. CNS Spectr. 2009;14:10-13.
50. Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:451-462.
51. Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009;34:917-923.
52. Chini B, Manning M, Guillon G. Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an "easy guide" to receptor pharmacology. In: Landgraf R, Neumann I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin-From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:513-517.
53. Scott LV, Dinan TG. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord. 2002;72:113-124.
54. Shimazaki T, Iijima M, Ito A, et al. Blockade of vasopressin V1b receptor displays anxiolytic and antidepressant effects in animal models. Journal of Pharmacological Sciences. 2007;103:233P.
55. Adolphs R. The Social Brain: Neural Basis of Social Knowledge. Annu Rev Psychol. 2009;60:693-716.
56. Swain JE, Lorberbaum JP, Kose S, Strathearn L. Brain basis of early parent-infant interactions: psychology, physiology, and in vivo functional neuroimaging studies. J Child Psychol Psychiatry. 2007;48:262-287.
57. Zeki S. The neurobiology of love. FEBS Lett. 2007;581:2575-2579.